Literature DB >> 17088672

Pediatric femoral fractures: a systematic review of 2422 cases.

Rudolf W Poolman1, Mininder S Kocher, Mohit Bhandari.   

Abstract

BACKGROUND: The incidence of femoral fractures in children comprise 20 per 100,000 yearly in the United States and Europe. The treatment of femoral shaft fractures in the pediatric population remains controversial. The child's age often directs the management. Nonoperative treatment options include functional treatment for the very young, Pavlic harness, skin or skeletal traction, and spica casting. Operative treatment options include closed reduction and external fixation, open reduction and internal plate fixation, closed reduction and minimally invasive plate osteosynthesis (MIPO), and closed reduction and intramedullary nailing with either flexible or rigid nails. The effect of operative versus nonoperative treatment has been the focus of several comparative studies.
OBJECTIVE: To determine the effect of different treatment options on the rate of union, malunion, leg-length discrepancy (LLD), complications, and outcome after femoral shaft fractures in children.

Entities:  

Mesh:

Year:  2006        PMID: 17088672     DOI: 10.1097/01.bot.0000247073.79430.87

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  19 in total

1.  Management of pediatric diaphyseal femur fractures.

Authors:  Benton E Heyworth; Catherine A Suppan; Dennis E Kramer; Yi-Meng Yen
Journal:  Curr Rev Musculoskelet Med       Date:  2012-02-09

2.  [Growth behavior after femoral shaft fractures: feasibility of patient therapy targets].

Authors:  D Schneidmueller; C Kraft; V Bühren; L von Laer
Journal:  Unfallchirurg       Date:  2014-12       Impact factor: 1.000

3.  Less malunion and shorter bone union time with titanium elastic nail treatment for isolated femoral shaft fractures in three- to six-year-old children.

Authors:  Gokay Eken; Cenk Ermutlu; Bartu Sarisozen; Teoman Atici; Kemal Durak; Adnan Cakar
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-02-18

4.  [Femoral shaft fractures in children under 3 years old. Current treatment standard].

Authors:  P C Strohm; P P Schmittenbecher
Journal:  Unfallchirurg       Date:  2015-01       Impact factor: 1.000

5.  Submuscular bridge plating for complex pediatric femur fractures is reliable.

Authors:  Amr A Abdelgawad; Ryan N Sieg; Matthew D Laughlin; Juan Shunia; Enes M Kanlic
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

6.  An observational cohort study of the adoption of elastic stable intramedullary nailing for the treatment of pediatric femur fractures in Kumasi, Ghana.

Authors:  Scott P Kaiser; Tai Holland; Paa Kwesi Baidoo; Richard C Coughlin; Peter Konadu; Dominic Awariyah; Raphael A Kumah-Ametepey
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

7.  Intramedullary nails for pediatric diaphyseal femur fractures in older, heavier children: early results.

Authors:  Richard A K Reynolds; Julie E Legakis; Ronald Thomas; Theddy F Slongo; James B Hunter; Jean-Michel Clavert
Journal:  J Child Orthop       Date:  2012-05-22       Impact factor: 1.548

8.  Does Shorter Time to Treatment of Pediatric Femur Shaft Fractures Impact Clinical Outcomes?

Authors:  Jennifer Grauberger; Megan O'Byrne; Anthony A Stans; William J Shaughnessy; A Noelle Larson; Todd A Milbrandt
Journal:  J Pediatr Orthop       Date:  2020-07       Impact factor: 2.537

Review 9.  Pediatric Femoral Shaft Fracture: An Age-Based Treatment Algorithm.

Authors:  Glen Zi Qiang Liau; Hong Yi Lin; Yuhang Wang; Kameswara Rishi Yeshayahu Nistala; Chin Kai Cheong; James Hoi Po Hui
Journal:  Indian J Orthop       Date:  2020-10-10       Impact factor: 1.251

10.  Childhood femoral fracture can lead to premature knee-joint arthritis. 21-year follow-up results: a retrospective study.

Authors:  Sauli A Palmu; Martina Lohman; Reijo T Paukku; Jari I Peltonen; Yrjänä Nietosvaara
Journal:  Acta Orthop       Date:  2013-01-23       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.